Maternal infection, a complex and multifaceted facet of maternal health, underscores the intricate interplay between infectious agents and pregnancy. The gravid state alters the immune response, rendering pregnant individuals both more susceptible to certain infections and potentially more vulnerable to severe complications. Maternal infections can arise from a variety of sources, including bacteria, viruses, parasites, and fungi, each presenting unique challenges in the context of pregnancy. Understanding the impact of maternal infections is paramount, as they can influence not only the health of the pregnant person but also have far-reaching consequences for fetal development and neonatal outcomes. Infections such as urinary tract infections (UTIs), bacterial vaginosis, and sexually transmitted infections (STIs) are common concerns during pregnancy. Left untreated, these infections may contribute to adverse outcomes, including preterm birth, low birth weight, or neonatal infections. The management of maternal infections requires a delicate balance, as certain antimicrobial agents may pose risks to the developing fetus. Thus, the careful consideration of the potential benefits and risks guides healthcare providers in determining the most appropriate course of treatment.
Viral infections, such as cytomegalovirus (CMV), herpes simplex virus (HSV), and human immunodeficiency virus (HIV), present unique challenges in the realm of maternal-fetal medicine. Maternal infections with these viruses may have profound implications for fetal development, ranging from congenital anomalies to neurodevelopmental disorders. The prevention, early detection, and management of maternal viral infections are critical components of prenatal care, necessitating a multidisciplinary approach involving obstetricians, infectious disease specialists, and neonatologists. Prevention is a key tenet in addressing maternal infections, and preconception care plays a vital role in identifying and managing potential infectious risks before pregnancy. Strategies such as vaccination, safer sexual practices, and lifestyle modifications contribute to reducing the likelihood of maternal infections and their associated complications. The symposium will also address the broader societal impact of maternal infections, emphasizing the importance of public health initiatives and education to empower individuals and communities in the prevention of infectious diseases during pregnancy.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia